Table 1 Baseline clinical characteristics classified by cancer status among HIV-infected inpatients at Beijing Ditan Hospital, January 1, 2008 – December 31, 2013

Total

1797

149

50

99

0.045

 Female

359 (20.0)

40 (26.8)

15 (30.0)

25 (25.3)

 Male

1438 (80.0)

109 (73.2)

35 (70.0)

74 (74.7)

Age (years)

Median (IQR)

37 (30–45)

44 (37–53)

50 (39–57)

42 (36–49)

0.026

0.002

 21–30

466 (25.9)

14 (9.4)

1 (2.0)

13 (15.4)

 31–40

621 (34.6)

48 (32.2)

14 (28.0)

34 (34.3)

 41–50

455 (25.3)

37 (24.8)

8 (16.0)

29 (29.3)

 51–60

171 (9.5)

32 (21.5)

16 (32.0)

16 (16.2)

  ≥ 61

84 (4.7)

18 (12.1)

11 (22.0)

7 (7.1)

0.085

 Men who have sex with men

635 (35.3)

35 (23.5)

6 (12.0)

29 (29.3)

 Injection drug use

81 (4.5)

2 (1.3)

0 (0.0)

2 (2.0)

 Heterosexual contact

800 (44.5)

83 (55.7)

31 (62.0)

52 (52.5)

 Blood transmission

224 (12.5)

24 (16.1)

12 (24.0)

12 (12.1)

 Unknown

57 (3.2)

5 (3.4)

1 (2.0)

4 (4.0)

Median days from HIV diagnosis to the first hospital admission (IQR)

111 (27–663)

215 (49–760)

350 (58–847)

140 (36–402)

0.015

Median first CD4 cell count after HIV diagnosis (IQR) (cells/μl)

131 (36–265)

127 (51–369)

146 (85–402)

91 (20–255)

0.213

 0–200

997 (55.5)

79 (53.0)

26 (56.0)

53 (51.5)

 201–350

422 (23.5)

29 (19.5)

10 (20.0)

19 (19.2)

 351–500

245 (13.6)

27 (18.1)

8 (16.0)

19 (19.2)

  > 500

133 (7.4)

14 (9.4)

6 (12.0)

8 (8.1)

Median CD4 cell count at the first hospital admission (IQR) (cells/μl)

289 (135–441)

265 (115–374)

297 (201–396)

240 (95–351)

0.381

ART initiation before the first hospital admission

1206 (67.1)

78 (52.3)

29 (58.0)

49 (49.5)

0.004

The CD4 cell count at ART initiation

147 (60–273)

137 (66–265)

160 (90–297)

102 (36–228)

0.067